Veeva Systems (NYSE:VEEV) is a highly capitalized growth stock that many investors haven’t heard about, despite its ubiquitous presence in the life sciences industry. Some of the company’s operating segments include data & analytics, clinical, R&D, and regulatory control software. Veeva Systems is also one of the few exceptions in the cloud software industry that has consistently grown its revenues and earnings for each financial year, and it’s expected to grow to $1.835B in revenue and $730M in earnings by the end of FY 2022. Q1 2022 hedge fund letters, conferences and more Veeva System’s Hea…